John J. Faragon, PharmD,BCPS, AAHIV-P
Regional Pharmacy Director, NY/NJ AIDS Education & Training Center
Albany Medical Center
Albany, New York
Release Date: March 2014
Continuing Education Credit Expiration Date: December 31, 2014
After reading this self-study module, you should be able to:
1. Discuss recent changes regarding the use of integrase inhibitors in treatment-naïve patients, as stated in the Department of Health and Human Services Guidelines.
2. Describe the role of raltegravir, elvitegravir, and dolutegravir in the management of HIV treatment-naïve subjects.
3. List common side effects and potential drug interactions associated with raltegravir, elvitegravir, and dolutegravir.
4. Review the role of integrase inhibitors for the management of post-exposure prophylaxis.
AMA PRA Category 1 Credit™
Albany Medical College is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Albany Medical College designates this Enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Click on the picture below
to view, save or print
To submit your paperwork electronically and receive an attendance certificate instantly, click on the link below:
This resource is a collaborative initiative among the Division of HIV Medicine at Albany Medical College and the New York/New Jersey AIDS Education & Training Center.
This resource is funded in part by the U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau.
Past Modules Below
Our previous modules which are no longer accredited for continuing education are posted below. Simply click on the image of the picture to view, save or print.